Is regression of chronic nephropathies a therapeutic target?
Remuzzi
Giuseppe
G
Remuzzi
Andrea
A
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000818:Animals; D002908:Chronic Disease; D006801:Humans; D007674:Kidney Diseases / Q000628:therapy*; D012074:Remission Induction
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors